Hjem › Leverkreft (hepatocellulært karcinom) › Massachusetts › Boston
Kliniske studier for Leverkreft (hepatocellulært karcinom) i Boston, MA
18 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #7, Boston
National Liver Cancer Screening Trial
RekruttererFase 4
- Massachusetts General Hospital, Boston
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekruttererFase 1
- Mass General Cancer Center, Boston
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
RekruttererFase 2
- Massachusetts General Hospital, Boston
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RekruttererObservasjonsstudie
- Mass General Brigham, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Dana-Farber Cancer Institute, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
RekruttererFase 3
- Massachusetts General Hospital Cancer Center, Boston
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
RekruttererFase 1/2
- Research Site, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
RekruttererFase 1/2
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
RekruttererFase 1
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
Computer Guided Microwave Liver Ablation
Rekrutterer
- Massachusetts General Hospital, Boston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
RekruttererFase 2
- Children's Hospital Boston, Boston
- Dana Farber Cancer Institute, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruttererFase 4
- Massachussets General Hospital, Boston
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
RekruttererObservasjonsstudie
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown · 1 mi unna
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
Rekrutterer
- Massachusetts General Hospital, Boston
Leverkreft (hepatocellulært karcinom)-studier i andre byer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
- San Antonio, TX13 studier
Andre studier i Boston
- Brystkreft112 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)85 studier
- Metastatisk kreft63 studier
- Kolorektal kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.